Skip to main content

Month: April 2024

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares

BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that it has commenced an underwritten public offering of $100 million of American Depositary Shares (“ADSs”), each representing one ordinary share. All of the ADSs are being offered by Centessa. In addition, Centessa intends to grant the underwriters a 30-day option to purchase up to an additional $15 million of ADSs offered in the public offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Goldman Sachs and Leerink Partners are acting as lead...

Continue reading

Artisan Partners Asset Management Inc. Reports 1Q24 Results

MILWAUKEE, April 23, 2024 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM) (the “Company” or “Artisan Partners”) today reported its results for the three months ended March 31, 2024, and declared a quarterly dividend. The full March 2024 quarter earnings release and investor presentation can be viewed at www.apam.com. Conference Call The Company will host a conference call on April 24, 2024, at 1:00 p.m. (Eastern Time) to discuss its results for the three months ended March 31, 2024. Hosting the call will be Eric Colson, Chief Executive Officer, Jason Gottlieb, President, and C.J. Daley, Chief Financial Officer. Supplemental materials that will be reviewed during the call are available on the Company’s website at www.apam.com. The call will be webcast and can be accessed via the Company’s website. Listeners...

Continue reading

Stride Posts Another Record Quarter

RESTON, Va., April 23, 2024 (GLOBE NEWSWIRE) — Stride, Inc. (NYSE: LRN), one of the nation’s leading technology-based education companies, today announced its results for the third fiscal quarter ended March 31, 2024. Third Quarter Fiscal 2024 Highlights Compared to 2023Revenue of $520.8 million, compared with $470.3 million, driven by continued strong enrollment trends. Income from operations of $88.3 million, compared with $72.2 million. Net income of $69.7 million, compared with $55.5 million. Diluted net income per share of $1.60 compared with $1.30. Adjusted operating income of $96.4 million, compared with $80.2 million. (1) Adjusted EBITDA of $120.5 million, compared with $103.9 million. (1)Third Quarter Fiscal 2024 Summary Financial Metrics  Three Months Ended March 31,   Change 2024/2023    2024      2023     $   %    (In thousands,...

Continue reading

Retail Opportunity Investments Corp. Reports 2024 First Quarter Results

SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) — Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the three months ended March 31, 2024. HIGHLIGHTS$11.0 million of net income attributable to common stockholders ($0.09 per diluted share) $37.9 million in Funds From Operations (FFO)(1) ($0.28 per diluted share) FFO per diluted share guidance for 2024 reaffirmed ($1.03 – $1.09 per diluted share) 5.7% increase in same-center cash net operating income (1Q‘24 vs. 1Q‘23) 383,293 square feet of leases executed during 1Q‘24 (207,172 square feet of anchor renewals) 96.4% portfolio lease rate at 3/31/24 (40th consecutive quarter above 96.0%) 179,464 square feet of anchor space leasing currently lined up 12.2% increase in same-space cash base rents on new leases (6.7% on renewals) $70.1...

Continue reading

CN Declares Second-Quarter 2024 Dividend

MONTREAL, April 23, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) announced today that its Board of Directors has approved a second-quarter 2024 dividend on the Company’s common shares outstanding. A quarterly dividend of eighty-four and a half cents (C$0.8450) per common share will be paid on June 28, 2024, to shareholders of record at the close of business on June 7, 2024. About CNCN is a world-class transportation leader and trade-enabler. Essential to the economy, to the customers, and to the communities it serves, CN safely transports more than 300 million tons of natural resources, manufactured products, and finished goods throughout North America every year. CN’s network connects Canada’s Eastern and Western coasts with the U.S. South through an 18,800 mile rail network. CN and its affiliates have been contributing...

Continue reading

Nokia Corporation: Repurchase of own shares on 23.04.2024

Nokia CorporationStock Exchange Release23 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 23.04.2024 Espoo, Finland – On 23 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 385,615 3.40CEUX – –BATE – –AQEU – –TQEX – –Total 385,615 3.40* Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Continue reading

Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor

First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation RAPNO LGG overall response rate (ORR) of 51% Day One receives rare pediatric disease priority review voucher Conference call and webcast to be April 24, 8:30 a.m. Eastern Time BRISBANE, Calif., April 23, 2024 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a commercial-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved OJEMDA (tovorafenib), a type II RAF inhibitor, for the treatment of patients 6 months of age and older with relapsed or refractory...

Continue reading

SCWorx Corp. Receives Expected Notice from NASDAQ Stock Market Pertaining to its 10-K of December 31, 2023

NEW YORK, N.Y., April 23, 2024 (GLOBE NEWSWIRE) — On April 17, 2024, SCWorx Corp. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Form 10-K for the period ended December 31, 2023 with the Securities and Exchange Commission (“SEC”), the Company has failed to satisfy a standard for continued listing, namely  Nasdaq Listing Rule 5250(c)(1) , which requires timely filing of all required periodic reports with the SEC. According to the Notice, the Company has 60 calendar days to submit a plan to regain compliance.  While the Company can provide no assurances as to timing, the Company is working with its independent registered public accounting firm to complete the audit of its financial statements as expeditiously as possible,...

Continue reading

Interoil’s Annual Statement of Reserves 2023 released

Oslo, 23 April 2024 Interoil Exploration and Production ASA today released the Annual Statement of Reserves for 2023. Please find the document attached. The report is also available on the company website. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act and is prepared in accordance with Oslo Stock Exchange’s Listing and disclosure requirements for oil and natural gas companies. + + + Please direct any question to ir@interoil.no Interoil Exploration and Production ASA is a Norwegian based exploration and production company – listed on the Oslo Stock Exchange – with focus on Latin America. The Company is operator and license holder of several production and exploration assets in Colombia and Argentina. Interoil currently employs approximately...

Continue reading

Twin Disc Announces Update to Timing of its Fiscal 2024 Third Quarter Earnings Webcast and Conference Call

MILWAUKEE, April 23, 2024 (GLOBE NEWSWIRE) — Twin Disc, Inc. (NASDAQ: TWIN), today announced an update to the timing of its fiscal 2024 third-quarter earnings webcast and conference call to 11:00 am Eastern on April 30, 2024 from the previously scheduled time of 9:00 am Eastern on April 30, 2024. The Company will still release its fiscal 2024 third-quarter results at approximately 8:00 am Eastern on April 30, 2024. The live audio webcast will be available on Twin Disc’s website at https://ir.twindisc.com. To participate in the conference call, please dial (800) 715-9871 approximately ten minutes before the call is scheduled to begin. A replay of the webcast will be available at https://ir.twindisc.com shortly after the call until April 29, 2025. About Twin DiscTwin Disc, Inc. designs, manufactures and sells marine and heavy-duty...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.